Global Niemann-Pick Disease Type C Treatment market size is expected to reach $4.46 billion by 2030 at 8.8%, rising prevalence of alzheimer’s disease fueling the growth of the market due to shared neurodegenerative research
Read MoreGlobal Niemann-Pick Disease (NPD) market size is expected to reach $1.79 billion by 2030 at 10.8%, the growing adoption of gene therapy driving the market growth by addressing genetic mutations and enhancing treatment outcomes
Read MoreGlobal NGS Oncology market size is expected to reach $32.87 by 2030 at 11.2%, increasing cancer prevalence fueling the growth of the market due to rising demand for precision diagnostics
Read MoreThe NGS data analysis market is projected to reach $3.93 by 2030, growing at 21.5% CAGR, driven by AI integration, cloud analytics, and personalized medicine applications.
Read MoreGlobal Next-Generation Gynecological Cancer Diagnostics market size is expected to reach $5.12 billion by 2030 at 11.3%, surging prevalence of gynecological malignancies to drive market growth
Read MoreGlobal Next-Generation Antibody Therapeutics market size is expected to reach $12.63 billion by 2030 at 10.9%, next-generation antibody therapeutics is a vital solution in addressing the surge of chronic diseases
Read MoreThe NGS sample preparation market is projected to reach $7.1 billion by 2030, growing at 14.5% CAGR, driven by automation, high-throughput workflows, and diagnostic sequencing demand.
Read MoreThe Next Generation Sequencing (NGS) in agrigenomics market size is expected to reach $4.48 billion in 2030 at 12.1%, driven by advanced sequencing technologies
Read MoreGlobal Next Generation Immunotherapies market size is expected to reach $262.82 billion by 2030 at 11.8%, rising cancer prevalence driving growth in the market
Read MoreThe Next Generation Cancer Diagnostics market size is expected to reach $26.44 billion in 2030 at 12.9%, driven by rising focus on precision oncology.
Read More
